These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 34974854)

  • 1. Strategies for Engineering Exosomes and Their Applications in Drug Delivery.
    Zhu M; Li S; Li S; Wang H; Xu J; Wang Y; Liang G
    J Biomed Nanotechnol; 2021 Dec; 17(12):2271-2297. PubMed ID: 34974854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles (EVs)' journey in recipient cells: from recognition to cargo release.
    Xiang H; Bao C; Chen Q; Gao Q; Wang N; Gao Q; Mao L
    J Zhejiang Univ Sci B; 2024 Aug; 25(8):633-655. PubMed ID: 39155778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery Applications.
    Sharma S; Masud MK; Kaneti YV; Rewatkar P; Koradia A; Hossain MSA; Yamauchi Y; Popat A; Salomon C
    Small; 2021 Oct; 17(42):e2102220. PubMed ID: 34216426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy.
    Xie F; Zhou X; Fang M; Li H; Su P; Tu Y; Zhang L; Zhou F
    Adv Sci (Weinh); 2019 Dec; 6(24):1901779. PubMed ID: 31871860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment.
    Srivastava A; Rathore S; Munshi A; Ramesh R
    Semin Cancer Biol; 2022 Nov; 86(Pt 1):80-100. PubMed ID: 35192929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in the development and establishment of exosome-based drug delivery systems.
    Wang J; Chen D; Ho EA
    J Control Release; 2021 Jan; 329():894-906. PubMed ID: 33058934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biogenesis of Extracellular Vesicles.
    Kang T; Atukorala I; Mathivanan S
    Subcell Biochem; 2021; 97():19-43. PubMed ID: 33779912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next.
    Song Y; Kim Y; Ha S; Sheller-Miller S; Yoo J; Choi C; Park CH
    Am J Reprod Immunol; 2021 Feb; 85(2):e13329. PubMed ID: 32846024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes and Other Extracellular Vesicles with High Therapeutic Potential: Their Applications in Oncology, Neurology, and Dermatology.
    Szwedowicz U; Łapińska Z; Gajewska-Naryniecka A; Choromańska A
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic and diagnostic applications of extracellular vesicles.
    Stremersch S; De Smedt SC; Raemdonck K
    J Control Release; 2016 Dec; 244(Pt B):167-183. PubMed ID: 27491882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the Choice of the Extracellular Vesicles for Therapeutic Purposes.
    Campanella C; Caruso Bavisotto C; Logozzi M; Marino Gammazza A; Mizzoni D; Cappello F; Fais S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicles for Therapeutic Nucleic Acid Delivery: Loading Strategies and Challenges.
    Oshchepkova A; Zenkova M; Vlassov V
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases.
    de Freitas RCC; Hirata RDC; Hirata MH; Aikawa E
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential fates of biomolecules delivered to target cells via extracellular vesicles.
    Kanada M; Bachmann MH; Hardy JW; Frimannson DO; Bronsart L; Wang A; Sylvester MD; Schmidt TL; Kaspar RL; Butte MJ; Matin AC; Contag CH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1433-42. PubMed ID: 25713383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Exosomes-Based Drug Delivery Systems.
    Gutierrez-Millan C; Calvo Díaz C; Lanao JM; Colino CI
    Macromol Biosci; 2021 Jan; 21(1):e2000269. PubMed ID: 33094544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.